LIVE FROM CPHI: Azelis agrees polyvinylpyrolidones (PVP) partnership with JH Nanhang

Published: 22-Oct-2013
Ingredients

For pharmaceutical applications across Europe, Russia, Turkey and North Africa


Speciality chemical distributor Azelis has fsigned an exclusive agreement with JH Nanhang (JHNH) to supply the Chinese company's range of polyvinylpyrolidones (PVP) for pharmaceutical applications across Europe, Turkey, Russia, Tunisia, Morocco and Algeria.

JHNH is owned by the JianHua Group and is the leading PVP manufacturer in China with an annual production of 5,000 metric tons from a plant in Quzhou.

The company meets all international standards for quality and safety including cGMP, ISO 9001 and ISO 14001 certifications. Its pharmaceutical products are marketed under the Povidone trade name from a newly established office in Shanghai and conform to USP/EP/JP with drug master files available.

The Povidone pharmaceutical range is suitable for a wide variety of applications including binders and stabilisiers for tablets, film formers and solubilisers for injection preparations, and disintegrants for tables, capsules and granules. To support their introduction, Azelis plans to provide prototype formulations and laboratory support, inviting customers for product training days and lab visits.

The two companies have a shared vision to drive market expansion and sustainable business development by providing high quality products, backed by good after sales care.

'Azelis is recognised for dedicated sales, marketing, technical support and supply chain excellence in the pharmaceutical industry,' said Tan Tiow Lin, General Manager, Global Sales and Marketing JHNH.

'At JHNH, we look forward to working with the Azelis pharma team to provide in-depth application insight to customers, helping to improve product performance and optimise cost-effectiveness.'

Matthew Dickman, International Business Director, Azelis Pharma, added: 'I am certain that this agreement will strengthen both our businesses across Europe, Russia, Turkey and North Africa, while at the same time giving our customers access to all that this key Chinese manufacturer can offer.'

  • Companies:
  • Azelis Group
See more

You may also like

Distribution

Azelis and Medichem extend partnership to DACH for the pharmaceutical, personal and home care markets

Read more
Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry, is pleased to announce a new distribution agreement with Medichem, a developer and manufacturer of active pharmaceutical ingredients (APIs) and final dosage forms (FDFs)

Trending Articles

  1. Get ahead in the pharmaceutical industry with a Manufacturing Chemist subscription With a Manufacturing Chemist subscription you receive exclusive access to the latest news, technical insights, regulatory updates, and market intelligence
  2. Mastering modified-release performance: excipient considerations Imagine a world where enhanced therapeutic efficacy, improved patient compliance and reduced adverse effects are tangible outcomes — even for drugs with short pharmacokinetic (PK) half-lives or narrow therapeutic indices. This is becoming a reality with modified-release (MR) oral delivery systems such as hydrophilic matrix tablets
  3. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  4. Rousselot Biomedical launches EU MDR compliant gelatin range From May 2024, all devices placed on the European market must conform with the EU Medical Device Regulation (MDR)
  5. Europa Biosite acquires life science product and service supplier, AMSBIO Europa Biosite will now be able to expand its presence across the key US market, while also bolstering its offerings in stem cell research, regenerative medicine and biospecimens

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Distribution

Azelis and Medichem extend partnership to DACH for the pharmaceutical, personal and home care markets

Azelis, a leading global innovation service provider in the specialty chemicals and food ingredients industry, is pleased to announce a new distribution agreement with Medichem, a developer and manufacturer of active pharmaceutical ingredients (APIs) and final dosage forms (FDFs)
Ingredients

Azelis completes Megafarma acquisition in Mexico

Megafarma is a premier speciality chemicals and food ingredient distributor
Ingredients

Azelis to enter Latin America with the acquisition of Megafarma

The transaction is expected to be completed within the next month
Ingredients

Azelis to acquire Turkish specialty chemicals distributor Ekin Kimya

The Istanbul-based company supplies chemicals for pharma, food ingredients and laboratory applications
Ingredients

Azelis gains a leading position in Australia and NZ with acquisition of Chemcolour

Azelis has agreed to fully acquire Chemcolour, a leading provider of specialty chemicals and food ingredients in Australia and New Zealand (ANZ)
Ingredients

Global cerium market estimated to grow strongly by 2021

Caprylic acid is used as raw material in manufacturing of surfactants, disinfectants, as an oil base and as emulsifiers in emulsion polymerisation.
Ingredients

New brand positioning for Azelis

Following its transformation into a global distributor of speciality chemicals and ingredients
Subscribe now